Presymptomatic and longitudinal neuroimaging in neurodegeneration - From snapshots to motion picture: A systematic review

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 10, 2015, Pages 1089-1096

  Schuster, Christina ^a   Elamin, Marwa ^a   Hardiman, Orla ^a   Bede, Peter ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALCOHOL ABUSE; ALCOHOLISM; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASYMPTOMATIC DISEASE; ATAXIA; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; EXTRAPYRAMIDAL SYNDROME; FRONTOTEMPORAL DEMENTIA; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; HYPERSALIVATION; LONGITUDINAL STUDY; MAGNETOENCEPHALOGRAPHY; METHODOLOGY; MOTOR NEURON DISEASE; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SAMPLE SIZE; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; META ANALYSIS; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY;

DISEASE PROGRESSION; HUMANS; LONGITUDINAL STUDIES; NEURODEGENERATIVE DISEASES; NEUROIMAGING; PROSPECTIVE STUDIES;

EID: 84942108971     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309888     Document Type: Article

References (50)

1. Lam BY, Halliday GM, Irish M, et al. Longitudinal white matter changes in frontotemporal dementia subtypes. Hum Brain Mapp 2014;35:3547-57.
2. Bede P, Bokde A, Elamin M, et al. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol 2013;84:766-73.
3. Grothe M, Heinsen H, Teipel S. Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease. Neurobiol Aging 2013;34:1210-20.
4. Knopman DS, Jack CR Jr, Kramer JH, et al. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology 2009;72:1843-9.
5. Whitwell JL, Jack CR Jr, Boeve BF, et al. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 2009;72:813-20.
6. Lu PH, Thompson PM, Leow A, et al. Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis 2011;23:433-42.
7. Bede P, Bokde AL, Byrne S, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology 2013;81:361-9.
8. Bede P, Elamin M, Byrne S, et al. Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology 2013;81:2107-15.
9. Ruocco HH, Bonilha L, Li LM, et al. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry 2008;79:130-5.
10. Pavese N, Moore RY, Scherfler C, et al. In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study. Exp Neurol 2010;222:120-4.
11. Tabrizi SJ, Reilmann R, Roos RA, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 2012;11:42-53.
12. Kalra S, Tai P, Genge A, et al. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J Neurol 2006;253:1060-3.
13. Orru G, Pettersson-Yeo W, Marquand AF, et al. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review. Neurosci Biobehav Rev 2012;36:1140-52.
14. Aylward EH, Sparks BF, Field KM, et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004;63:66-72.
15. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain 1996;119 (Pt 6): 2001-7.
16. Tang CC, Poston KL, Dhawan V, et al. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 2010;30:1049-56.
17. Turner MR, Hammers A, Al-Chalabi A, et al. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain 2005;128(Pt 6): 1323-9.
18. Agosta F, Rocca MA, Valsasina P, et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2009;80:53-5.
19. El Mendili MM, Cohen-Adad J, Pelegrini-Issac M, et al. Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis. PLoS ONE 2014;9:e95516.
20. Freund P, Wheeler-Kingshott C, Jackson J, et al. Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity. Mult Scler 2010;16:1193-202.
21. Teipel SJ, Peters O, Heuser I, et al. Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: effect of different processing and analysis approaches on sample sizes. World J Biol Psychiatry 2011;12(Suppl 1):109-13.
22. Turner MR, Grosskreutz J, Kassubek J, et al. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 2011;10:400-3.
23. Fjell AM, Westlye LT, Grydeland H, et al. Critical ages in the life course of the adult brain: nonlinear subcortical aging. Neurobiol Aging 2013;34:2239-47.
24. Fjell AM, McEvoy L, Holland D, et al. Brain changes in older adults at very low risk for Alzheimer's disease. J Neurosci 2013;33:8237-42.
25. Menke RA, Korner S, Filippini N, et al. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain 2014;137(Pt 9):2546-55.
26. Ciarmiello A, Giovacchini G, Orobello S, et al. 18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Med Mol Imaging 2012;39:1030-6.
27. McDonald CR, McEvoy LK, Gharapetian L, et al. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 2009;73:457-65.
28. Leung KK, Bartlett JW, Barnes J, et al. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 2013;80:648-54.
29. Nowrangi MA, Lyketsos CG, Leoutsakos JM, et al. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement 2013;9:519-28.
30. Sabuncu MR, Desikan RS, Sepulcre J, et al. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol 2011;68:1040-8.
31. Verstraete E, Veldink JH, van den Berg LH, et al. Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis. Hum Brain Mapp 2014;35:1351-61.
32. Laakso MP, Lehtovirta M, Partanen K, et al. Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study. Biol Psychiatry 2000;47:557-61.
33. Hall CB, Lipton RB, Sliwinski M, et al. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med 2000;19:1555-66.
34. Gomeni R, Fava M. Amyotrophic lateral sclerosis disease progression model. Amyotroph Lateral Scler frontotemporal degener 2014;15:119-29.
35. Simon NG, Turner MR, Vucic S, et al. Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol 2014;76:643-57.
36. Balendra R, Jones A, Jivraj N, et al. Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials. J Neurol Neurosurg Psychiatry 2015;86:45-9.
37. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012;11:232-40.
38. Eisen A, Kiernan M, Mitsumoto H, et al. Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry 2014;85:1232-8.
39. Cellura E, Spataro R, Taiello AC, et al. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2012;114:550-4.
40. van der Graaff MM, Sage CA, Caan MW, et al. Upper and extra-motoneuron involvement in early motoneuron disease: a diffusion tensor imaging study. Brain 2011;134(Pt 4):1211-28.
41. Rohrer JD, Ridgway GR, Modat M, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage 2010;53:1070-6.
42. Frings L, Mader I, Landwehrmeyer BG, et al. Quantifying change in individual subjects affected by frontotemporal lobar degeneration using automated longitudinal MRI volumetry. Hum Brain Mapp 2012;33:1526-35.
43. Verstraete E, van den Heuvel MP, Veldink JH, et al. Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PLoS ONE 2010;5:e13664.
44. Tabrizi SJ, Scahill RI, Owen G, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol 2013;12:637-49.
45. Acosta-Cabronero J, Alley S, Williams GB, et al. Diffusion tensor metrics as biomarkers in Alzheimer's disease. PLoS ONE 2012;7:e49072.
46. Bede P, Elamin M, Byrne S, et al. Patterns of cerebral and cerebellar white matter degeneration in ALS. J Neurol Neurosurg Psychiatry 2014;86:468-76.
47. Bak TH, Chandran S. What wires together dies together: verbs, actions and neurodegeneration in motor neuron disease. Cortex 2012;48:936-44.
48. Chio A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310-23.
49. Kassubek J, Muller HP, Del Tredici K, et al. Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology. Brain 2014;137(Pt 6):1733-40.
50. Radue EW, O'Connor P, Polman CH, et al. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. Arch Neurol 2012;69:1259-69.